Medication abortion with mifepristone and misoprostol has the potential to advance women’s access to safe and geographically accessible abortion care. Improved access to medication abortion protects women’s right to health and supports women’s autonomy and agency. However, the over-regulation of mifepristone in much of the Global North has muted the promise of this pill-based regimen […]
Read More